Comparison of Two Ventilation Methods for Micro-Laryngeal Surgery

Hopital Foch3 enrolled

Overview

Single-center, randomized study, comparing two methods of oxygenation on 80 patients

This study is a single-center, randomized study, comparing two methods of oxygenation during micro-laryngeal surgery performed under general anesthesia and myorelaxation: high-flow nasal oxygen therapy (HFNO) or Flow Controlled Ventilation (FCV) using a laryngeal tri-tube. The study population will be composed of 80 patients, aged over 18 and under 80.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Laryngeal Disease

Interventions

High-flow nasal oxygen therapy using a specific nasal cannulaDEVICE

Patient in this arm will received high-flow nasal oxygen therapy ventilation during the ENT surgery

Flow Controlled Ventilation using a laryngeal tri-tubeDEVICE

Patient in this arm will received a laryngeal tri-tube ventilation during the ENT surgery

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient over the age of 18 and under the age of 80 * Patient to benefit from micro-laryngeal ENT surgery under general anesthesia and myorelaxation with an estimated duration which does not exceed 30 minutes * Having signed a consent form * Being affiliated with a Health Insurance plan. Exclusion Criteria: * Pregnant or lactating patient * Patient with a weight \<40 kg * Obese patient (BMI\> 30) * Patient with foreseeable intubation difficulty * Patient maintained under general anesthesia postoperatively * Surgery requiring time by surgical laser * Surgery involving the use of an active electrosurgical electrode in the immediate area of the electrosurgical device or electrode * Predictable surgery longer than 30 minutes * Being deprived of liberty or under guardianship.

Locations (1)

Hopital Foch

Suresnes, France

Outcomes

Primary Outcomes

Compare the percentage of patients having oxygen desaturation during the procedure or a PaCO2 > 65 mmHg at its end with both methods (high-flow nasal oxygen therapy and the use of FCV modality via a laryngeal tri-tube).

% of patients having an oxygen desaturation (SpO2\<92%) during the procedure OR a PaCO2 \> 65 mmHg at its end